跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,103 条关于
“GAMMAGARD S/D”
全部
21,103
临床试验
7,436
药物
3,189
机构
3,292
资讯
7,186
去年
FDA Approves Takeda's GAMMAGARD LIQUID ERC, First Ready-to-Use Low IgA Immunoglobulin Therapy for Primary Immunodeficiency
7个月前
Takeda Launches GAMMAGARD LIQUID ERC, First Ready-to-Use Low-IgA Immunoglobulin Therapy in U.S.
6个月前
D&D Pharmatech and First Bio Secure European Patent for Novel Brain Disease Drug NLY02
4个月前
D&D Pharmatech Raises $165M as MASH Drug DD01 Approaches Key Phase 2 Readout
去年
D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01
2年前
Galapagos' ATALANTA-1 Clinical Trial for Hemophilia A to Expand to the US Following IND Clearance
2年前
Cell Therapy Shows Promise in Progressive Multiple Sclerosis
去年
CAR-T Therapy Demonstrates Significant Reduction in Multiple Myeloma Disease Burden
去年
Benitec BioPharma's Gene Therapy Shows Promising Results in Oculopharyngeal Muscular Dystrophy Trial
去年
Liso-cel Demonstrates Significant Response in Relapsed/Refractory Marginal Zone Lymphoma
第 1 页,共 719 页
上一页
下一页